Sol Gel Technologies Ltd (SLGL)

Currency in USD
39.3200
-1.6700(-4.07%)
Closed·
38.8300-0.4900(-1.25%)
·
SLGL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SLGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.000042.5800
52 wk Range
4.006052.2600
Key Statistics
Prev. Close
40.99
Open
41.26
Day's Range
38-42.58
52 wk Range
4.006-52.26
Volume
11.84K
Average Volume (3m)
22.84K
1-Year Change
486.41%
Book Value / Share
11.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SLGL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Sol Gel Technologies Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Sol Gel Technologies Ltd Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Compare SLGL to Peers and Sector

Metrics to compare
SLGL
Peers
Sector
Relationship
P/E Ratio
−32.1x−5.1x−0.7x
PEG Ratio
−0.43−0.120.00
Price/Book
3.4x3.4x2.6x
Price / LTM Sales
4.6x5.7x3.4x
Upside (Analyst Target)
−2.4%83.5%35.7%
Fair Value Upside
Unlock5.4%4.1%Unlock

Earnings

Latest Release
Aug 15, 2025
EPS / Forecast
-1.57 / -0.67
Revenue / Forecast
5.89M / 2.86M
EPS Revisions
Last 90 days

SLGL Income Statement

People Also Watch

10.2700
ORBS
-9.20%
219.36
ALAB
+3.42%
1.580
OVID
-5.39%
35.65
VSAT
+13.93%
43.246
RGTI
-1.51%

FAQ

What Stock Exchange Does Sol Gel Tech Trade On?

Sol Gel Tech is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sol Gel Tech?

The stock symbol for Sol Gel Tech is "SLGL."

What Is the Sol Gel Tech Market Cap?

As of today, Sol Gel Tech market cap is 117.84M.

What Is Sol Gel Tech's Earnings Per Share (TTM)?

The Sol Gel Tech EPS (TTM) is -1.22.

When Is the Next Sol Gel Tech Earnings Date?

Sol Gel Tech will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is SLGL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sol Gel Tech Stock Split?

Sol Gel Tech has split 1 times.

How Many Employees Does Sol Gel Tech Have?

Sol Gel Tech has 34 employees.

What is the current trading status of Sol Gel Tech (SLGL)?

As of 08 Oct 2025, Sol Gel Tech (SLGL) is trading at a price of 39.3200, with a previous close of 40.99. The stock has fluctuated within a day range of 38.0000 to 42.5800, while its 52-week range spans from 4.0060 to 52.2600.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.